
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **KCNK15**: A potassium channel involved in maintaining the resting membrane potential.<br>- **IFI27, IFI6, ISG15, IFITM1, IFITM3**: Interferon-induced genes, often associated with immune response and antiviral activities.<br>- **HSPB1**: A heat shock protein involved in stress response and protein folding.<br>- **GSTM3**: A glutathione S-transferase involved in detoxification processes.<br>- **COX6C, COX6A1, NDUFA13, ATP5F1E**: Components of the mitochondrial electron transport chain, indicating active metabolism.<br>- **MIF**: Macrophage migration inhibitory factor, involved in immune response and inflammation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT18, KRT8, KRT19**: Keratins typically expressed in epithelial cells, particularly luminal epithelial cells in the breast.<br>- **AGR2, AGR3**: Associated with secretory epithelial cells, often found in breast tissue.<br>- **CST6**: Cystatin E/M, a marker for epithelial cells, particularly in breast tissue.<br>- **CLDN3**: Claudin 3, a tight junction protein, often found in epithelial cells.<br>- **TFF3**: Trefoil factor 3, associated with mucosal protection and repair, often expressed in epithelial cells.<br>- **TMEM64, TMEM205**: Transmembrane proteins, often associated with epithelial cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer and epithelial cell markers, we can confirm that many of these markers are associated with epithelial cells, particularly luminal epithelial cells in the breast.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of keratins (KRT18, KRT8, KRT19), AGR2, AGR3, and other epithelial markers, the most probable general cell type is **epithelial cells**. Given the context of breast cancer tissue, these are likely to be **luminal epithelial cells**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: The presence of KRT18, KRT8, KRT19, AGR2, and AGR3 strongly suggests luminal epithelial cells, which are common in breast tissue.<br>2. **Basal Epithelial Cells**: Although less likely due to the lack of specific basal markers like KRT5 or KRT14, some overlap in epithelial markers could suggest a basal subtype.<br>3. **Myoepithelial Cells**: While not strongly indicated, the presence of some stress response and immune-related genes could suggest a minor myoepithelial component.<br><br>The most likely subtype, based on the markers, is **Luminal Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of luminal epithelial cells. This conclusion is supported by the high expression of keratins (KRT18, KRT8, KRT19) and other markers such as AGR2 and AGR3, which are characteristic of luminal epithelial cells in the breast. The presence of interferon-induced genes and mitochondrial components suggests active metabolism and potential stress response, which are consistent with the cellular environment in breast cancer tissue.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation of the cell cluster as "Luminal Epithelial Cells" is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:<br><br>1. **Marker Consistency**: <br>   - The key markers used in the annotation, such as KRT18, KRT8, KRT19, AGR2, AGR3, and CST6, are present in the provided marker list. These markers are well-known for their association with epithelial cells, particularly luminal epithelial cells in breast tissue.<br>   - Additional markers like CLDN3 and TFF3 further support the epithelial nature of the cells.<br><br>2. **Mixed Cell Type Consideration**:<br>   - While there are markers like IFI27, IFI6, ISG15, and IFITM1 that are associated with immune response, their presence can be attributed to the stress response and active metabolism typical in cancerous tissues rather than indicating a distinct immune cell population.<br>   - The annotation acknowledges the potential presence of basal and myoepithelial cells but correctly identifies them as less likely due to the lack of specific markers for these subtypes.<br><br>Overall, the annotation is well-supported by the marker list and aligns with known characteristics of luminal epithelial cells in breast cancer tissue. No strong evidence suggests a mixed cell type population that would require further investigation.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Basal Epithelial Cells</li><li>Myoepithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough and methodical approach to identifying the cell types present in the single-cell dataset derived from breast cancer tissue. The analysis correctly identifies the main cell type as epithelial cells, with a strong emphasis on luminal epithelial cells, which is consistent with the expression of key markers such as KRT18, KRT8, KRT19, AGR2, and AGR3. These markers are well-known for their association with luminal epithelial cells in breast tissue, and their presence in the marker list supports the annotation.<br><br>The analysis also considers other potential cell types, such as basal epithelial cells and myoepithelial cells, but correctly identifies them as less likely due to the lack of specific markers for these subtypes. This demonstrates a balanced consideration of multiple markers and avoids over-focusing on any single marker, which is a strength of the analysis.<br><br>The inclusion of interferon-induced genes and mitochondrial components is noted, and their presence is attributed to the stress response and active metabolism typical in cancerous tissues. This consideration adds depth to the analysis, acknowledging the complex cellular environment in breast cancer tissue.<br><br>However, while the annotation is generally accurate, there is a slight oversight in not fully exploring the potential implications of the immune-related markers (e.g., IFI27, IFI6, ISG15, IFITM1) beyond stress response. Although the analysis concludes that these markers do not indicate a distinct immune cell population, a more detailed exploration of their potential roles could have provided a more comprehensive view.<br><br>Overall, the annotation is scientifically accurate, well-balanced in its use of different markers, and provides a comprehensive view of the cell types present. There are no obvious misclassifications, and the analysis captures the general picture of the cell populations effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    